APA

Viscuse P. V., Price K. A., Garcia J. J., Schembri-Wismayer D. J. & Chintakuntlawar A. V. (2019). First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study. : Frontiers in oncology.

Chicago

Viscuse Paul V, Price Katharine A, Garcia Joaquin J, Schembri-Wismayer David J and Chintakuntlawar Ashish V. 2019. First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study. : Frontiers in oncology.

Harvard

Viscuse P. V., Price K. A., Garcia J. J., Schembri-Wismayer D. J. and Chintakuntlawar A. V. (2019). First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study. : Frontiers in oncology.

MLA

Viscuse Paul V, Price Katharine A, Garcia Joaquin J, Schembri-Wismayer David J and Chintakuntlawar Ashish V. First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study. : Frontiers in oncology. 2019.